How Doctors Diagnose a Spongy Heart
At a Glance
LVNC diagnosis cannot be based on a heart muscle ratio alone. Doctors combine echocardiogram or cardiac MRI criteria with pumping function, symptoms, family history, and LGE scarring because athletic training, pregnancy, and normal variation can create a spongy appearance.
When you look at an imaging report for Left Ventricular Noncompaction (LVNC), you will often see various measurements and “ratios.” It is important to understand that these numbers are used to describe the look of your heart muscle, but they are not always enough to diagnose a disease on their own [1]. Doctors use specific sets of “rules” called imaging criteria to evaluate if your heart qualifies as “noncompacted.” There is no universally accepted gold-standard criterion, and an experienced doctor will interpret these numbers alongside your symptoms and overall heart function.
Two Common Imaging Criteria: Jenni and Petersen
Because the heart looks different depending on whether it is being viewed with ultrasound or MRI, there are different sets of criteria used:
- The Jenni Criteria (Echocardiogram): This is commonly used for ultrasound. A doctor looks at the “spongy” (noncompacted) layer and the solid (compacted) layer at the end of a heartbeat, when the heart is most contracted [2]. If the spongy layer is more than twice as thick as the solid layer (a ratio of >2.0), along with deep recesses with blood flow, it meets the Jenni criteria [3].
- The Petersen Criteria (Cardiac MRI): MRI provides a much more detailed picture. For this test, the layers are measured when the heart is relaxed and filled with blood [4]. Because the muscle is more stretched out during this phase, the threshold is slightly higher: the spongy layer must be more than 2.3 times the thickness of the solid layer to meet the Petersen criteria [5].
Why Healthy Hearts Can Meet These Criteria
One of the biggest challenges with these criteria is that they can be “too sensitive.” This means they often “overcall” the condition, identifying hypertrabeculation in healthy people who don’t actually have a heart disease [6][7].
Your heart is a dynamic organ that changes shape based on the work it has to do. Certain situations can cause a healthy heart to develop more “mesh-like” muscle bundles:
- Athletes: People who do intense endurance training often develop larger, more trabeculated hearts as a normal response to exercise [8]. In some specific athletic cohorts, a significant percentage may meet the imaging criteria without having any actual heart problem [9]. However, athletes should never assume a finding is benign without a full clinical review.
- Pregnancy: During pregnancy, the amount of blood the heart has to pump increases significantly. This extra load can cause the heart muscle to temporarily appear more noncompacted [10]. While it often returns to normal after delivery, pregnancy can also unmask true cardiomyopathy, so careful follow-up is necessary [1].
- Ancestry: Research in specific cohorts suggests that individuals of certain ancestries, including those of African descent, may naturally have more prominent heart muscle bundles. However, ancestry is never a substitute for thorough individual assessment [11].
Late Gadolinium Enhancement (LGE): A Vital Risk Marker
If you have a cardiac MRI, your doctor may use a special contrast dye called gadolinium to look for Late Gadolinium Enhancement (LGE). This looks for fibrosis—which is essentially microscopic scarring in the heart muscle [4].
LGE is not a required diagnostic criterion to say you have LVNC, but it is an incredibly important marker for risk stratification [12]. Research has shown that:
- Higher Risk: Patients with significant LGE have a higher risk of heart rhythm problems (arrhythmias) and heart failure, even if their heart’s pumping function (ejection fraction) is still normal [13][14].
- Scarring vs. Appearance: In studies, the simple ratio of “sponginess” did not reliably predict who would have health issues [15]. However, the presence and pattern of LGE-related scarring was strongly associated with future heart health [16][12].
If your MRI shows no LGE and you have normal pumping function, this lowers the concern, but it does not completely guarantee safety or prove your heart is just a normal variant. Diagnosis is a “puzzle” where the imaging ratio is just one piece; your symptoms, family history, and the presence of scarring are integrated by your specialist to determine your actual long-term risk [17][13].
Common questions in this guide
What imaging criteria are used to diagnose LVNC?
Can a healthy person meet the imaging criteria for a spongy heart?
What does LGE mean on a cardiac MRI for LVNC?
Does a normal ejection fraction rule out problems with LVNC?
Why does the timing of the heart measurements matter?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Left ventricular noncompaction.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which diagnostic criteria were used to evaluate my heart—Jenni, Petersen, or another method?
- 2.What was my specific 'noncompacted-to-compacted' ratio, and was it measured during the heart's contraction or relaxation phase?
- 3.Could my activity level as an athlete (or recent pregnancy) be causing my heart to look this way as a normal adaptation?
- 4.Was Late Gadolinium Enhancement (LGE) found on my MRI, and what does the presence or absence of scarring mean for my risk of arrhythmias?
- 5.How do my pumping function (ejection fraction) and heart size compare to the trabeculation measurements in terms of my overall diagnosis?
References
References (17)
- 1
What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question.
Di Lisi D, Macaione F, Damiani F, et al.
Current problems in cardiology 2024; (49(11)):102787 doi:10.1016/j.cpcardiol.2024.102787.
PMID: 39137881 - 2
Long-Term Survival of Patients With Left Ventricular Noncompaction.
Vaidya VR, Lyle M, Miranda WR, et al.
Journal of the American Heart Association 2021; (10(2)):e015563 doi:10.1161/JAHA.119.015563.
PMID: 33441029 - 3
Left ventricular noncompaction-a rare cause of triad: heart failure, ventricular arrhythmias, and systemic embolic events: a case report.
Toader D, Paraschiv A, Tudorașcu P, et al.
Journal of medical case reports 2021; (15(1)):316 doi:10.1186/s13256-021-02862-x.
PMID: 34099054 - 4
Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.
Andreini D, Pontone G, Bogaert J, et al.
Journal of the American College of Cardiology 2016; (68(20)):2166-2181 doi:10.1016/j.jacc.2016.08.053.
PMID: 27855806 - 5
Three-dimensional Whole-Heart Cardiac MRI Sequence for Measuring Trabeculation in Left Ventricular Noncompaction.
Polacin M, Károlyi M, Wilzeck V, et al.
Radiology. Cardiothoracic imaging 2022; (4(6)):e220109 doi:10.1148/ryct.220109.
PMID: 36601458 - 6
Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?
Weir-McCall JR, Yeap PM, Papagiorcopulo C, et al.
Journal of the American College of Cardiology 2016; (68(20)):2157-2165 doi:10.1016/j.jacc.2016.08.054.
PMID: 27855805 - 7
A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults.
Ross SB, Jones K, Blanch B, et al.
European heart journal 2020; (41(14)):1428-1436 doi:10.1093/eurheartj/ehz317.
PMID: 31143950 - 8
Left Ventricular Noncompaction Syndrome.
Strubchevska K, Strubchevska O, Kozyk M, et al.
Cardiology in review 2026; doi:10.1097/CRD.0000000000001206.
PMID: 41680975 - 9
Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic Criteria.
Masso AH, Uribe C, Willerson JT, et al.
Texas Heart Institute journal 2020; (47(3)):183-193 doi:10.14503/THIJ-19-7157.
PMID: 32997774 - 10
Rethinking Left Ventricular Noncompaction and Excessive Left Ventricular Trabeculation: Development, Genetics, and a Proposed Conceptual Framework.
Hirono K
Journal of clinical medicine 2026; (15(18)) doi:10.3390/jcm15187175.
PMID: 42795946 - 11
Left Ventricular Non-Compaction Cardiomyopathy: A Review of the Pathophysiology, Epidemiology, Diagnosis, Genetics, and Clinical Management.
Martínez-Tittonel LE, Ciorba FR, Bayona-Huguet X, Kaplinsky E
Journal of personalized medicine 2025; (15(10)) doi:10.3390/jpm15100484.
PMID: 41149846 - 12
Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.
Femia G, Zhu D, Choudhary P, et al.
International journal of cardiology 2021; (328()):235-240 doi:10.1016/j.ijcard.2020.12.017.
PMID: 33309759 - 13
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction.
Grigoratos C, Barison A, Ivanov A, et al.
JACC. Cardiovascular imaging 2019; (12(11 Pt 1)):2141-2151 doi:10.1016/j.jcmg.2018.12.029.
PMID: 30878415 - 14
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
Casas G, Limeres J, Oristrell G, et al.
Journal of the American College of Cardiology 2021; (78(7)):643-662 doi:10.1016/j.jacc.2021.06.016.
PMID: 34384546 - 15
Comparison of cardiovascular magnetic resonance characteristics and clinical consequences in children and adolescents with isolated left ventricular non-compaction with and without late gadolinium enhancement.
Cheng H, Lu M, Hou C, et al.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2015; (17()):44 doi:10.1186/s12968-015-0148-7.
PMID: 26024839 - 16
The prognostic role of CMR using global planimetric criteria in patients with excessive left ventricular trabeculation.
Macaione F, Meloni A, Positano V, et al.
European radiology 2021; (31(10)):7553-7565 doi:10.1007/s00330-021-07875-0.
PMID: 33821336 - 17
Left Ventricular Non-Compaction in Athletes: To Play or Not to Play.
Coris EE, Moran BK, De Cuba R, et al.
Sports medicine (Auckland, N.Z.) 2016; (46(9)):1249-59 doi:10.1007/s40279-016-0512-2.
PMID: 27002622
This page explains how imaging criteria and MRI findings are used to evaluate LVNC for educational purposes only and does not constitute medical advice. Your cardiologist should interpret your results alongside your symptoms, heart function, and family history.